Data / Form D filings / MediProPharma, Inc.
MediProPharma, Inc.: Form D filings
MediProPharma, Inc., a biotechnology company in Midvale, UT, filed 2 Form D notices with the SEC in 2009. The latest, on November 13, 2009, reports $645,000 sold of a $770,280 offering to 8 investors.
Find out what MediProPharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 359 EAST UNION MILL DRIVE, Midvale, UT, 84047
- Phone
- (801) 856-7341
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1474737
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2009 | Amendment | $770,280 | $645,000 | $125,280 | 8 | Oct 1, 2009 | sec.gov |
| Oct 16, 2009 | New notice | $770,280 | $645,000 | $125,280 | 8 | Oct 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas N. Parks | Director | |
| Irina Shcherbakova | Executive Officer, Director | |
| Theodore H. Stanley | Director | |
| S. George Simon | Executive Officer, Director | |
| Shane A. Johnson | Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 14 LLC offering · Nov 9, 2026
- Life Impact Partners 15 LLC offering · Nov 9, 2026
- Life Impact Partners 7 LLC offering · Nov 6, 2026
- Life Impact Partners 6 LLC offering · Nov 6, 2026
- Life Impact Partners 3 LLC offering · Nov 6, 2026
- Life Impact Partners 5 LLC offering · Nov 6, 2026
- Life Impact Partners 4 LLC offering · Nov 6, 2026
- Life Impact Partners 2 LLC offering · Nov 6, 2026
- Life Impact Partners 8 LLC offering · Nov 6, 2026
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Nov 9, 2009 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MediProPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.